Kidney Cancer Treatment Market By Treatment (Targeted Therapy, Immunotherapy, Radiation Therapy, Neurosurgical Treatments (Cryoablation, Radio frequency ablation), By Class of drugs (mTOR Inhibitors, Angiogenesis Inhibitors, Monoclonal Antibodies, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography.

 

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

kidney cancer treatment market is expected to grow at significant rates owing to the technological advancements in the treatment such as advent of ablation techniques and growing prevalence of cancer. Kidney cancer also is known as renal cancer. It is the type of cancer which occurs in or affects the kidney. There are several types of kidney cancers among them renal cell carcinoma, urothelial carcinoma, lymphoma, sarcoma and wills tumour are main types. Renal cell carcinoma is most common type of kidney cancer and occupies about 85% of kidney cancers patients and occurs in adults. Wills tumour most commonly occurs in children. Furthermore, market players in the global and local markets are expanding their product portfolio and geographical reach by various strategies such as acquisition, collaboration. For instance, in May 2016, BTG has acquired a cryoablation product manufacturer for the treatment and palliative care for kidney and other cancers, Galil Medical for about $84.5m. In addition, companies also focus on new product developments and R&D to expand their market share. For instance, in November 2017, UK-based EUSA Pharma and the USA’s AVEO Oncology has launched Fotivda (tivozanib) for the treatment of adult patients with advanced renal cell carcinoma in Germany.

kidney cancer treatment market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report gives historical, current, and future market sizes (US$ Mn) on the basis of treatment, class of drugs, distribution channel and region. This report studies global kidney cancer treatment market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition

Kidney Cancer Treatment Market Summary

Study Period

2023-29

Base Year

2022

CAGR

X%

Largest Market

North America

Fastest Growing Market

N/A
Kidney Cancer Treatment Market

kidney cancer treatment market is expected to grow at significant rates owing to the factors such as increase in prevalence of kidney cancer due to the lifestyle changes and increase in smoking and consuming alcohol. In addition, increase in geriatric population who are more prone to the kidney related diseases coupled with the increase in R&D support and investments by the government in screening of cancer and in development of new treatment of drugs. Furthermore, availability of kidney cancer treating drugs are low, it is likely to act as growth opportunity for development of new drug treatments for the treatment. However, high prices of available branded drugs for the treatment of kidney cancer and high R&D expenditure for the development of new drugs are expected to hinder the market growth over the forecast period.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2016-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analys

Kidney Cancer Treatment Market Segmentation

Treatment
  • Targeted Therapy
  • Immunotherapy
  • Radiation Therapy
  • Neurosurgical Treatments
    • Cryoablation
    • Radiofrequency ablation
Drug Class
  • mTOR Inhibitors
  • Angiogenesis Inhibitors
  • Monoclonal Antibodies
  • Others
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa.

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Table of Content
  1. Executive Summary
  2. Global Kidney Cancer Treatment Market Introduction
    • Global Kidney Cancer Treatment Market – Taxonomy
    • Global Kidney Cancer Treatment Market –Definitions
      • Treatment
      • Class of Drugs
      • Distribution Channel
  1. Global Kidney Cancer Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Kidney Cancer Treatment Market Dynamic Factors - Impact Analysis
    • Global Kidney Cancer Treatment Market – Competition Landscape
    • Epidemiology
  2. Global Kidney Cancer Treatment Market Analysis,2013 - 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Kidney Cancer Treatment Market, By Treatment, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
    • Targeted Therapy
      • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Immunotherapy
      • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Radiation Therapy
      • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Neurosurgical Treatments
      • Cryoablation
        • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
      • Radiofrequency ablation
        • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
        • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
        • Market Opportunity Analysis
  1. Global Kidney Cancer Treatment Market Forecast, By Class of Drugs,2013 - 2017 and Forecast, 2018 – 2024
    • mTOR Inhibitors
      • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Angiogenesis Inhibitors
      • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Monoclonal Antibodies
      • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Kidney Cancer Treatment Market Forecast, By Distribution Channel, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
    • Hospital Pharmacies
      • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Kidney Cancer Treatment Market Forecast, By Region, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Kidney Cancer Treatment Market - Opportunity Analysis Index, By Treatment, By Class of Drugs, By Distribution Channel and Region, 2018 – 2024
  2. North America Kidney Cancer Treatment MarketAnalysis,2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
    • Treatment Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Targeted Therapy
      • Immunotherapy
      • Radiation Therapy
      • Neurosurgical Treatments
        • Cryoablation
        • Radiofrequency ablation
      • Class of Drugs Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • mTOR Inhibitors
        • Angiogenesis Inhibitors
        • Monoclonal Antibodies
        • Others
      • Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
        • Others
      • Country Analysis 2016 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • S.
        • Canada
      • North America Kidney Cancer Treatment Market - Opportunity Analysis Index, By Treatment, By Class of Drugs, By Distribution Channel and Country, 2018 – 2024
      • North America Kidney Cancer Treatment Market Dynamics – Trends
  1. Europe Kidney Cancer Treatment Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
    • Treatment Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Targeted Therapy
      • Immunotherapy
      • Radiation Therapy
      • Neurosurgical Treatments
        • Cryoablation
        • Radiofrequency ablation
      • Class of Drugs Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • mTOR Inhibitors
        • Angiogenesis Inhibitors
        • Monoclonal Antibodies
        • Others
      • Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
        • Others
      • Country Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Germany
        • UK
        • France
        • Spain
        • Italy
        • Russia
        • Poland
        • Rest of Europe
      • Europe Kidney Cancer Treatment Market - Opportunity Analysis Index, By Treatment, By Class of Drugs, By Distribution Channel and Country,2018 – 2024
      • Europe Kidney Cancer Treatment Market Dynamics – Trends
  1. Asia-Pacific Kidney Cancer Treatment Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
    • Treatment Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Targeted Therapy
      • Immunotherapy
      • Radiation Therapy
      • Neurosurgical Treatments
        • Cryoablation
        • Radiofrequency ablation
      • Class of Drugs Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • mTOR Inhibitors
        • Angiogenesis Inhibitors
        • Monoclonal Antibodies
        • Others
      • Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
        • Others
      • Country Analysis2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Japan
        • China
        • India
        • ASEAN
        • Australia & New Zealand
        • Rest of Asia-Pacific
      • Asia-Pacific Kidney Cancer Treatment Market - Opportunity Analysis Index, By Treatment, By Class of Drugs, By Distribution Channel and Country,2018 – 2024
      • Asia-Pacific Kidney Cancer Treatment Market Dynamics – Trends
  1. Latin America Kidney Cancer Treatment Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
    • Treatment Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Targeted Therapy
      • Immunotherapy
      • Radiation Therapy
      • Neurosurgical Treatments
        • Cryoablation
        • Radiofrequency ablation
      • Class of Drugs Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • mTOR Inhibitors
        • Angiogenesis Inhibitors
        • Monoclonal Antibodies
        • Others
      • Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
        • Others
      • Country Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Brazil
        • Mexico
        • Argentina
        • Venezuela
        • Rest of Latin America
      • Latin America Kidney Cancer Treatment Market - Opportunity Analysis Index, By Treatment, By Class of Drugs, By Distribution Channel and Country,2018 – 2024
      • Latin America Kidney Cancer Treatment Market Dynamics – Trends
  1. Middle East and Africa Kidney Cancer Treatment Market Analysis, 2013 - 2017 and Forecast, 2018 - 2024 (Revenue, USD Mn)
    • Treatment Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Targeted Therapy
      • Immunotherapy
      • Radiation Therapy
      • Neurosurgical Treatments
        • Cryoablation
        • Radiofrequency ablation
      • Class of Drugs Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • mTOR Inhibitors
        • Angiogenesis Inhibitors
        • Monoclonal Antibodies
        • Others
      • Distribution Channel Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
        • Others
      • Country Analysis 2013 - 2017 and Forecast 2018 - 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Gulf Cooperation Council (GCC) Countries
        • Israel
        • South Africa
        • Rest of MEA
      • MEA Kidney Cancer Treatment Market - Opportunity Analysis Index, By Treatment, By Class of Drugs, By Distribution Channel and Country,2018 – 2024
      • MEA Kidney Cancer Treatment Market Dynamics – Trends
  1. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Treatment& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Pfizer Inc. (U.S.)
      • GlaxoSmithKline Plc. (U.K.)
      • Bayer AG (Germany)
      • Novartis AG (Switzerland)
      • Hoffman-La Roche (Switzerland)
      • EUSA Pharma (U.K.)
      • BTG plc (U.K.)
  1. Research Methodology
  2. Key Assumptions and Acronyms
  • Pfizer Inc. (U.S.)
  • GlaxoSmithKline Plc. (U.K.)
  • Bayer AG (Germany)
  • Novartis AG (Switzerland)
  • Hoffman-La Roche (Switzerland)
  • EUSA Pharma (U.K.)
  • BTG plc (U.K.)